顎関節症に対するＡｍｆｅｎａｃ Ｓｏｄｉｕｍ（フェナゾックス）の臨床評価
書誌事項
- タイトル別名
-
- Clinical evaluation of amfenac sodium(Fenazox) on temporomandibular joint arthrosis.
抄録
Tendernesses and mouth opening pains at the region of temporomandibular joints and/or in masticatory muscles are very common on temporomandibular joint disorder patients.<BR>We usually give these patients anti-inframmatory analgesics or muscle relaxants until the treatment plan is decided, or when the splint therapy is ineffective for removing the tenderness or pain.<BR>Recently we have had an opportunity to use a new anti-inframmatory analgesic of arylacetate derivatives, Amfenac Sodium (AMF) to the patients who have temporomandibular joint disorders, and have evaluated the analgesic efficacy, side effect and usefulness of this analgesic.<BR>27 patients aged from 16 to 71 years (severity: mild 11, moderate 14 and severe 2) were given AFM (200 mg/day for 14 days) and evaluated symptoms were spontaneous pain, tenderness, mouth opening pain, interincisal opening range, clickin sound and crepitus at the 7th day and at the 14th day.<BR>As a result, total improvements were as follows: excellent 4 (14.8%), moderate 13 (48.1%), little 9 (33.3%), no change 1 (3.7%).<BR>6 side effects (22.2%) were reported, but those were mild (5 cases), or moderate (1 case). No severe side effect was found.<BR>Consequently, we concluded the usefulness of AMF as followed: very useful 4 (14.8%), luseful 12 (44.4%), relatively useful 10 (37.0%). Total usefulness including very useful, useful and relatively useful was 96.2%.
収録刊行物
-
- 日本口腔科学会雑誌
-
日本口腔科学会雑誌 37 (1), 242-263, 1988
特定非営利活動法人 日本口腔科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390282681412420992
-
- NII論文ID
- 130004335073
-
- ISSN
- 21850461
- 00290297
-
- 本文言語コード
- ja
-
- データソース種別
-
- JaLC
- CiNii Articles
-
- 抄録ライセンスフラグ
- 使用不可